18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2017
Price : $35 *
At a glance
- Drugs Flortaucipir-F-18 (Primary) ; Florbetapir F 18
- Indications Encephalopathy
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 19 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Dec 2014 Planned End Date changed from 1 Dec 2014 to 1 Jul 2015, according to the ClinicalTrials.gov record.